Skip to main content
Fig. 4 | Diagnostic Pathology

Fig. 4

From: Large cell morphology, CMYC+ tumour cells, and PD-1+ tumour cell/intense PD-L1+ cell reactions are important prognostic factors in nodal peripheral T-cell lymphomas with T follicular helper markers

Fig. 4

a No significant differences in overall survival (OS) were detected among 20 PTCL-TFH patients, 23 PTCL-NOS, and 38 AITL. b 12 large cell PTCL-TFH patients show significantly worse OS than small cell PTCL-TFH (n = 8; p = 0.045), AITL (n = 38; p = 0.047) and F-TCL (n = 6; p = 0.012). c CMYC+ tumour cells (n = 23) are a poor prognostic factor in 64 patients with TFH+ PTCLs (p = 0.029). d 22 patients with both PD-L1+ tumour cells and R3+ PD-L1+ cells show significantly worse OS than 42 with R1+ and R2+ PD-L1+ cells (p = 0.0004). e 21 patients with both PD-1+ tumour cells and high PD-L1+ group (n + and R3+) show significantly worse prognosis than 43 of the other group (p = 0.005). f 10 patients with both CMYC+ tumour cells and high PD-L1+ group show significantly poorer OS compared with 54 patients in the other groups of TFH+ PTCLs (p < 0.0001)

Back to article page